Special Issues

Special Issue Title: Clinical Electrophysiology: Diagnosis and Treatment

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 March 2022

Special Issue Editor

Guest Editor

Yoshiaki Kaneko, MD, PhD 

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi 371-8511, Gunma, Japan

Website | E-Mail

Interests: Clinical electrophysiology; Catheter ablation; Device therapy

Special Issue Information

Dear Colleagues,

I am proud to announce the special issue “Clinical Electrophysiology: diagnosis and treatment”. There have been remarkable recent advances in approaches/therapies for the management of cardiac arrhythmias. The field of cardiac electrophysiology has been characterized by a succession of advances in understanding the pathophysiology of cardiac arrhythmias and the application of innovative technologies to cure diverse supraventricular and ventricular arrhythmias. Development of novel concepts of arrhythmias has led a new strategy of curing the arrhythmias along with the progression of 3D technologies. As these results, most of arrhythmias including atrial fibrillation, ventricular tachycardia complicated with organic heart disease and some types of ventricular fibrillation have become curable by catheter-based approaches. The Special Issue will publish full research articles and systematic reviews. Potential topics include, but are not limited to, the following research areas: 
  ? Concept, electrophysiological diagnosis and ablation of supraventricular or ventricular tachyarrhythmias
  ? Technologies including imaging and mapping system
  ? Pathophysiology of tachyarrhythmias
  ? Meta-analysis of clinical trials
  ? Molecular biology and cellular physiology of inherited arrhythmias

We look forward to receiving your excellent work. 

Thank you very much!

Dr. Yoshiaki Kaneko

Guest Editor


Manuscript Submission Information

Manuscripts should be submitted online at https://rcm.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reviews in Cardiovascular Medicine is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1950. Submitted papers should be well formatted and use good English.


Supraventricular tachycardia; Ventricular tachycardia; Electrophysiologic study; Catheter ablation; Inhereted arrhythmias; Electroanatomical mapping; Atrioventricular node

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails
Influence of excess weight and obesity on performance and outcome of pulmonary vein isolation with the cryoballoon
Christian Blockhaus, Hans-Peter Waibler, Jan-Erik Gülker, Alexander Bufe, Melchior Seyfarth, Buelent Koektuerk, Dong-In Shin
Reviews in Cardiovascular Medicine    2021, 22 (3): 1047-1052.   DOI: 10.31083/j.rcm2203114
Abstract46)   HTML3)    PDF(pc) (148KB)(94)       Save

Pulmonary vein isolation (PVI) has become a cornerstone therapy in the treatment of atrial fibrillation (AF). Patients with overweight or obesity suffer more often from AF, and studies investigating the safety and feasibility of PVI in these patients have shown varying results. In this study we analyzed PVI performed with the 2nd generation cryoballoon (CB) with regard to safety, procedure and fluoroscopy time in patients with normal weight, overweight and obesity. We analyzed 228 consecutive patients treated with CB PVI in our hospital in 2018 and 2019. Fifty nine (25.88%) patients presented with normal weight (body mass index (BMI) of <25), 115 (50.44%) patients with overweight (BMI between 25 and 29.9) and 54 (23.68%) were obese patients (BMI >30). All pulmonary veins (PV) were isolated successfully. Concerning procedural parameters, neither complications, procedural time, nor fluoroscopy time differed significantly. There was a significant increase of dose area product (DAP) in obese patients compared to normal weight and overweight patients (2035.5 ± 1930.1 μGym2 vs. 975.3 ± 814.9 vs. 1325.1 ± 2081.3, p = 0.001) but no significant difference between overweight and normal weight patients (p = 0.611). Our follow-up data of 168 patients (73.68%) observed for 12 months showed no differences in the recurrence of AF in the three BMI groups [80.9% vs. 83.3% (p = 0.733) vs. 86.55% (p = 0.460)]. In conclusion, CB PVI in overweight and obese patients is safe with similar levels of complications and recurrence of AF as patients of normal weight. However, obese patients and operators are exposed to higher radiation doses.

Table and Figures | Reference | Related Articles | Metrics

Current Issue

  • Volume 22, Issue 3